Previous Article |
Table of Contents
| Next Article
Departments of * Medicine and Edited by Pedro M. Cuatrecasas, University of California School
of Medicine, San Diego, CA, and approved March 5, 2002 (received for review December 14, 2001)
In addition to its important functions in detoxification of
foreign chemicals and biosynthesis of steroid hormones, the cytochrome P450 enzyme system metabolizes arachidonate to
14,15-epoxyeicosatrienoic acid (14,15-EET). This study demonstrates
that a P450 arachidonate epoxygenase metabolite can activate cleavage
of heparin-binding epidermal growth factor-like growth factor (HB-EGF)
and delineates an essential role for HB-EGF in the mitogenic effects of
this lipid mediator. Blockade of HB-EGF processing or EGF receptor (EGFR) inhibited 14,15-EET-stimulated early mitogenic signals and DNA
synthesis. 14,15-EET failed to induce mitogenesis in cell lines
expressing minimal HB-EGF, whereas 14,15-EET induced soluble HB-EGF
release into the conditioned media of cell lines that both express high
levels of HB-EGF and display mitogenic response to this lipid mediator.
Moreover, transfection of a bacterial 14,15-epoxygenase established
intracellular endogenous 14,15-EET biosynthesis in cultured
cell systems, which allowed direct confirmation of involvement of EGFR
transactivation in the endogenous 14,15-EET-mediated
mitogenic signaling pathway. This mechanism involves
EET-dependent activation of metalloproteinases and release of
the potent mitogenic EGFR ligand, HB-EGF.
Cell Biology
Heparin-binding EGF-like growth factor mediates the
biological effects of P450 arachidonate epoxygenase metabolites in
epithelial cells
, and
Biochemistry, Vanderbilt
University, Nashville, TN 37232
To whom reprint requests should be addressed.
E-mail: ray.harris{at}mcmail.vanderbilt.edu.
www.pnas.org/cgi/doi/10.1073/pnas.092671899
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
U. R. Michaelis, N. Xia, E. Barbosa-Sicard, J. R. Falck, and I. Fleming Role of Cytochrome P450 2C Epoxygenases in Hypoxia-Induced Cell Migration and Angiogenesis in Retinal Endothelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhuang, G. R. Kinsey, K. Rasbach, and R. G. Schnellmann Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F459 - F468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Jiang, Y.-G. Ning, C. Chen, D. Ma, Z.-J. Liu, S. Yang, J. Zhou, X. Xiao, X. A. Zhang, M. L. Edin, et al. Cytochrome P450 Epoxygenase Promotes Human Cancer Metastasis Cancer Res., July 15, 2007; 67(14): 6665 - 6674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pozzi, M. R. Ibanez, A. E. Gatica, S. Yang, S. Wei, S. Mei, J. R. Falck, and J. H. Capdevila Peroxisomal Proliferator-activated Receptor-{alpha}-dependent Inhibition of Endothelial Cell Proliferation and Tumorigenesis J. Biol. Chem., June 15, 2007; 282(24): 17685 - 17695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kinugasa, M. Hieda, M. Hori, and S. Higashiyama The Carboxyl-terminal Fragment of Pro-HB-EGF Reverses Bcl6-mediated Gene Repression J. Biol. Chem., May 18, 2007; 282(20): 14797 - 14806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J.-K. Chen, J. R. Falck, S. Anjaiah, J. H. Capdevila, and R. C. Harris Mitogenic Activity and Signaling Mechanism of 2-(14,15- Epoxyeicosatrienoyl)Glycerol, a Novel Cytochrome P450 Arachidonate Metabolite Mol. Cell. Biol., April 15, 2007; 27(8): 3023 - 3034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, J.-K. Chen, E. G. Neilson, and R. C. Harris Role of EGF Receptor Activation in Angiotensin II-Induced Renal Epithelial Cell Hypertrophy J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1615 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming and R. Busse Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function Hypertension, April 1, 2006; 47(4): 629 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Michaelis, B. Fisslthaler, E. Barbosa-Sicard, J. R. Falck, I. Fleming, and R. Busse Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis J. Cell Sci., December 1, 2005; 118(23): 5489 - 5498. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pozzi, I. Macias-Perez, T. Abair, S. Wei, Y. Su, R. Zent, J. R. Falck, and J. H. Capdevila Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids J. Biol. Chem., July 22, 2005; 280(29): 27138 - 27146. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Michaelis, J. R. Falck, R. Schmidt, R. Busse, and I. Fleming Cytochrome P4502C9-Derived Epoxyeicosatrienoic Acids Induce the Expression of Cyclooxygenase-2 in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Singh, T. Tsukada, R. Zent, and R. C. Harris Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells J. Cell Sci., March 15, 2004; 117(8): 1365 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Xu, Y. Ding, J. Ling, Z. Dong, and F.-S. X. Yu Wound-Induced HB-EGF Ectodomain Shedding and EGFR Activation in Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 813 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nanba, A. Mammoto, K. Hashimoto, and S. Higashiyama Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF J. Cell Biol., November 10, 2003; 163(3): 489 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Potente, B. Fisslthaler, R. Busse, and I. Fleming 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1 J. Biol. Chem., August 8, 2003; 278(32): 29619 - 29625. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mascia, V. Mariani, G. Girolomoni, and S. Pastore Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation Am. J. Pathol., July 1, 2003; 163(1): 303 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newman, C. Morisseau, T. R. Harris, and B. D. Hammock The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity PNAS, February 18, 2003; 100(4): 1558 - 1563. [Abstract] [Full Text] [PDF] |
||||